partneringNEWS

Interview with Anja König, Managing Director, Novartis Venture Funds

ebd-admin — Thu, 09 Sep 2010 12:14:27 +0000

At BIO-Europe Spring® 2010 Anja König, managing director, Novartis Venture Funds, provides insight on how venture funds work and what strategic models have been successful for Novartis. Konig also reflects on the current market and what it means to future investments in biotech. Read more »

Ironwood: ‘We intend to be here for a very long time’

ctheodoropulos — Mon, 30 Aug 2010 16:15:42 +0000

Ironwood's James O’Mara is searching for new partners to expand opportunities either by in-licensing new products or by securing distribution for linaclotide, a late stage drug for gastrointestinal (GI) disorders. Read more »

No related posts.

BioServe: ‘On-demand biomaterials lower the risk of clinical trials’

ctheodoropulos — Mon, 30 Aug 2010 16:14:54 +0000

BioServe introduces an innovation in the supply-and-demand chain for biomaterials that allows researchers to simulate in preclinical experiments the exacting requirements a novel compound will be expected to face downstream in clinical phases. Read more »

No related posts.

ESC Advisors: ‘Independent judgment and experience for challenging times’

ctheodoropulos — Mon, 30 Aug 2010 16:14:37 +0000

ESC Advisors wants to meet with companies looking to raise capital at BioPharm America. "Working with smaller companies takes us beyond traditional investment banking because it gives us an opportunity to roll up our sleeves as an advisor to the company and work hands-on with the management team," says Evonne Sepsis, Founder, ESC Advisors. Read more »

No related posts.

War stories inspire partnering at BioPharm America™ 2010

ctheodoropulos — Tue, 27 Jul 2010 12:14:10 +0000

Daphne Zohar gathers a blue-ribbon panel of dealmakers for BioPharm America in Boston to focus on unexpected dynamics that can derail high profile transactions. In this interview, she provides fresh perspectives that challenge conventional views of partnering and describes the trail-blazing strategy of her firm, PureTech Ventures. Read more »

Nycomed: “Always, always looking for partners”

jbrosky — Tue, 27 Jul 2010 12:13:58 +0000

Ahead of BioPharm America 2010 in Boston, Nycomed's lead dealmaker, Kerstin Valinder, offers an in-depth discussion of partnering that jumps to the top of our 'Summer Reading' list. In this exclusive interview with partneringNEWS she traces the company's spectacular growth to EUR 3 billion in sales, outlines Nycomed's targets for further growth, and shares fresh views on how the 'professionalization' of partnering changes business development. Read more »

Smart Partnering: AstraZeneca offers tips for potential partners

BioTech Forum opens door to dealmaking in Scandinavia

jbrosky — Tue, 27 Jul 2010 12:13:41 +0000

The leading event for partnering in life sciences in Scandinavia, BioTech Forum this year is being held in concert with the landmark event ScanLab. Together these events will draw more than 6,000 participants to the Bella Center, September 28–30, 2010. Read more »

High-powered partnering in Boston at BioPharm America™

ctheodoropulos — Tue, 29 Jun 2010 12:43:31 +0000

As dealmaking reaches a peak in life sciences for 2010, BioPharm America™ presents an unrivalled opportunity to help companies raise capital, form licensing agreements, and enter co-development deals. Read more »

Millennium-Takeda: A nimble biotech with a global footprint

ctheodoropulos — Tue, 29 Jun 2010 12:41:42 +0000

“We see partnering as an integral part of building the business for the long term, and you can think of our business development efforts for partnering as building an external R&D engine,” said Anna Protopapas. Read more »

BioTech Forum opens door to dealmaking in Scandinavia

Smart Partnering: AstraZeneca offers tips for potential partners

ctheodoropulos — Tue, 29 Jun 2010 12:41:20 +0000

"Effective partnering is all about target marketing, which means having an in-depth and multi-dimensional view of your prospective partners’ needs. For the most part when biotech companies use an online web-enabled partnering system they employ an opposite approach—a mass marketing approach to partnering." Read more »

partneringNEWS

Interview with Anja König, Managing Director, Novartis Venture Funds

Related Posts

Ironwood: ‘We intend to be here for a very long time’

Related Posts

BioServe: ‘On-demand biomaterials lower the risk of clinical trials’

Related Posts

ESC Advisors: ‘Independent judgment and experience for challenging times’

Related Posts

War stories inspire partnering at BioPharm America™ 2010

Related Posts

Nycomed: “Always, always looking for partners”

Related Posts

BioTech Forum opens door to dealmaking in Scandinavia

Related Posts

High-powered partnering in Boston at BioPharm America™

Related Posts

Millennium-Takeda: A nimble biotech with a global footprint

Related Posts

Smart Partnering: AstraZeneca offers tips for potential partners

Related Posts